首页> 外文会议>Conference on biomedical photonics and optoelectronic imaging >Experimental Research of Photodynamic Diagnosis Mediated by Chemiluminescence Reagents
【24h】

Experimental Research of Photodynamic Diagnosis Mediated by Chemiluminescence Reagents

机译:化学发光试剂介导的光动力诊断的实验研究

获取原文

摘要

There are some serious limitations existing in conventional photodynamic diagnosis (PDD), such as autofluorescence disturbance, weak red-band absorption efficacy of traditional photosensitizers and quite short penetration depth of excitation light. In this paper a novel method of PDD mediated by chemiluminescence reagents is presentedi n fabricated mixed samples. Photodynamic therapy (PDT) is believed to act via singlet oxygen (~1O_2) generated by energy from photosensitizers~(1). 5-Fluoresceinyl Cypridina Luciferin Analog (FCLA), a chemiluminescence reagent, can react with singlet oxygen and emit chemiluminescence~(3) with peak wavelength about at 526 nm~(4). In the experiments, FCLA was chosen as an optical reporter of localization of singlet oxygen produced from photosensitized reaction of Hematoporphyrin Derivative (HpD) excited by 630 nm laser. Experimental results, the measurement of fluorescence spectra and the detection of iamge from chemiluminescnece, show that the mixed HpD & FCLA in biologic tissue mixture excited with the laser of 630 nm can emit detectable light signals.
机译:有现有的常规光动力诊断(PDD)一些严重的局限性,如自发荧光的干扰,传统的光敏剂的弱红色波段吸收功效和激发光的相当短的穿透深度。在本文中,通过化学发光试剂介导的PDD的新颖方法是presentediÑ制造混合样品。光动力疗法(PDT)被认为经由通过从光敏剂的能量〜(1)中产生的单线态氧(〜1O_2)采取行动。 5- Fluoresceinyl海萤荧光素模拟(FCLA),化学发光试剂,可以与用峰值波长约在526纳米〜(4)单重态氧,并发射化学发光〜(3)反应。在实验中,FCLA被选为由630 nm激光激发从血卟啉衍生物(HPD)的光敏反应产生单线态氧的定位的光学报道。实验结果,荧光光谱的测量和iamge从chemiluminescnece检测,表明血卟啉混合&FCLA在生物组织混合物用630nm的激光激发下,发射可检测的光信号。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号